AdaptHealth (NASDAQ:AHCO) Price Target Raised to $14.00 at Canaccord Genuity Group

AdaptHealth (NASDAQ:AHCO) had its price target increased by Canaccord Genuity Group from $13.00 to $14.00 in a research note released on Wednesday,Benzinga reports. They currently have a buy rating on the stock.

Several other equities research analysts also recently weighed in on AHCO. Truist Financial raised their price target on shares of AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a research report on Wednesday. Robert W. Baird reduced their target price on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a report on Wednesday, November 6th. UBS Group decreased their price target on AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Finally, Royal Bank of Canada increased their price objective on AdaptHealth from $11.00 to $14.00 and gave the company an “outperform” rating in a research report on Wednesday. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $13.40.

AdaptHealth Stock Up 4.3 %

NASDAQ:AHCO opened at $11.10 on Wednesday. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The firm has a market cap of $1.49 billion, a P/E ratio of -6.73, a P/E/G ratio of 1.08 and a beta of 1.12. AdaptHealth has a fifty-two week low of $8.35 and a fifty-two week high of $11.90. The firm has a 50-day simple moving average of $9.87 and a two-hundred day simple moving average of $10.21.

Institutional Investors Weigh In On AdaptHealth

A number of hedge funds have recently added to or reduced their stakes in the stock. Blue Trust Inc. boosted its stake in shares of AdaptHealth by 24.1% in the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock worth $55,000 after buying an additional 1,115 shares during the last quarter. Guggenheim Capital LLC lifted its holdings in AdaptHealth by 10.1% in the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company’s stock valued at $158,000 after acquiring an additional 1,525 shares during the period. Sterling Capital Management LLC boosted its position in AdaptHealth by 5.2% in the fourth quarter. Sterling Capital Management LLC now owns 33,558 shares of the company’s stock worth $319,000 after purchasing an additional 1,644 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its stake in shares of AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after purchasing an additional 1,690 shares during the period. Finally, Rhumbline Advisers increased its position in shares of AdaptHealth by 0.5% during the 4th quarter. Rhumbline Advisers now owns 313,110 shares of the company’s stock valued at $2,981,000 after purchasing an additional 1,691 shares during the last quarter. 82.67% of the stock is currently owned by hedge funds and other institutional investors.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.